Physician profile

Chace Barrett Mitchell

Surgery · Los Angeles, CA

NPI 1215565726

$1,523.41

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,523.41

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Baxter Healthcare $443.97 2023 Preveleak, Floseal, Coseal
Bolton Medical INC $316.58 2023 Relay Thoracic Stent-Graft With Plus Delivery System
Atricure, INC. $277.15 2023-2024
Edwards Lifesciences Corporation $173.74 2023 Mitris Resilia Mitral Valve
Abbott Laboratories $172.36 2024 Epic
Stryker Corporation $139.61 2023 Na

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Chace Barrett Mitchell

$1,523.41

in general payments reported 2019-2025

Years
2023-2024
Top company
Baxter Healthcare

https://glasscript.com/doctor/11527656/chace-barrett-mitchell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.